Reuters logo
9 天前
BRIEF-Sophiris Bio Q2 earnings per share $0.02
2017年8月10日 / 晚上9点26分 / 9 天前

BRIEF-Sophiris Bio Q2 earnings per share $0.02

Aug 10 (Reuters) - Sophiris Bio Inc

* Sophiris Bio reports second quarter financial results and key corporate highlights

* Q2 earnings per share $0.02

* Q2 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S

* Sophiris Bio- not planning on second Phase 3 trial in BPH, unless can secure development partner to fund new clinical trial or obtain other financing​

* Sophiris Bio Inc- ‍expects that its cash and cash equivalents will be sufficient to fund its operations through end of 2018​

* Sophiris Bio Inc- ‍expects to receive 24- week biopsy data for all patients from first dose of topsalysin in Q1 of 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below